drugset / Trial / NCT00997880

Statin and Atheroma Vulnerability Evaluation

NCT00997880 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of statin therapy on the modification of atherosclerotic plaque composition and vulnerability in non-intervened coronary arteries with mild to moderate stenosis using VH-IVUS and OCT.

Timeline

Start
2010-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg —
Subject Rosuvastatin Small molecule 40 mg —